Save the date

Truveta Symposium 2025

April 28 - 30 | Seattle, WA

Healthcare, public health, and life sciences Saving Lives with Data together

Interested in attending Symposium? Reach out

Truveta Symposium uniquely brings together leaders from health systems, life sciences, and the government to collaborate on health research with real-world data, embracing generative AI to transform healthcare, and improving patient care and outcomes for all.

See the agenda

Sessions and presentations include:

^Truveta’s vision for trusted real-time healthcare insights
^Using real-world data to augment journals and replace slow and expensive registries and clinical trials
^Breakthroughs, challenges, and the future of metabolic and cardiovascular health
^Revolutionizing infectious disease surveillance with real-time, real-world data
^Harnessing real-world data to train AI models for accelerating therapy development and improving patient outcomes
^Integrating wearable device data with medical outcomes to revolutionize diabetes management
^Pioneering use of real-world data to drive innovation in vascular health and medical devices
^Delivering high-value patient care through strategic healthcare-life science partnerships
^RWE or RCT? Using Truveta Data to bridge two worlds
^Truveta Genome Project: Harnessing the power of genomic medicine and EHR data

Agenda

At-a-glance

Monday, April 28
Welcome reception beginning at 5pm. Presentation at 7 pm on USA Healthcare Facts with Steve Ballmer, founder of USA Facts, former Microsoft CEO, and owner, LA Clippers.

Tuesday, April 29
Daylong featured research and panel presentations from 8 am-5 pm, followed by dinner on the Seattle waterfront.

Wednesday, April 30
Keynote featuring Jay Nanduri, Truveta CTO at 8:30 am, followed by healthcare and researcher custom tracks until 1pm, including topics on data, AI and biospecimens and technical research enablement trainings.

Expand to see full agenda

Truveta’s vision for trusted real-time healthcare insights	Terry Myerson, CEO and co-founder, Truveta
A bold new era in medical evidence: Using real-world data to augment journals and replace slow and expensive registries and clinical trials	Ken Stein, SVP and Global Chief Mecial Officer, Boston Scientific Michael Mack, MD, Co-chair NeuroARC and Chair, Cardiovascular Governance Council, and Medical Director, Cardiovascular Surgery, Baylor Scott & White Health Heather A. Rubino, PhD, MS, Head, Safety Surveillance Research, Pfizer Host: Ryan Ahern, Chief Medical Officer and co-founder, Truveta
Uncovering new insights through a broad research collaboration on GLP-1 medications and alcohol use	Tricia Rodriquez, Principal Applied Scientist, Truveta Joseph Levy, PhD, Assistand Professor, Johns Hopkins Bloomberg School of Public Health Ty Gluckman, MD, Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at Providence St. Joseph Health Jay Lusk, MD, MBA, Duke University Health System
Revolutionizing infectious disease surveillance with real-time, real-world data	Scott Kelly, Global Epidemiology, Pfizer
Harnessing real-world data to train AI models for accelerating therapy development and improving patient outcomes	David Tingley, PhD, Co-founder and CEO, Olio Labs
Integrating wearable device data with medical outcomes to revolutionize diabetes management	Michelle Tressler, PhD, Vice President, Strategic Planning, Dexcom
Revolutionizing vascular care: Boston Scientific’s pioneering use of real-world data to drive innovation of medical devices	Michael Jaff, DO, FACC, Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific
Unpacking the Adderall shortage: Increasing trends and downstream impacts	Brianna Cartwright, MS, Principal Research Analyst, Truveta
Delivering high-value patient care through strategic healthcare-life science partnership	Prof. Rifat Atun, Harvard Health Systems Innovation Lab Evelyn Vanvlasselaer, Global Head of Target Outputs, Boehringer-Ingelheim Petros Okubagzi, MD, Director, Cardiovascular Research Programs, MedStar Health
Understanding and improving health disparities with large electronic healthcare record data	Nasa Sinnott-Armstrong, PhD, Assistant Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred Hutch Cancer Center
RWE or RCT? Using Truveta to bridge two worlds	Ishu V. Rao, MD, Senior Vice President of Medical Affairs, Impulse Dynamics
The next evolution of RWD for cancer research	Michael Simonov, MD, Vice President of Product, Truveta
Truveta Genome Project: Harnessing the power of genomic medicine and EHR data	Jeff Boyd, PhD, Chief Scientific Officer, Director, Center of Genomic Medicine, Northwell Health Cancer Institute Aris Baras, MD, Senior Vice President, Regeneron and Head of Regeneron Genetics Center (RGC)

Presenters

Rifat Atun

Professor

Harvard Health Systems Innovation Lab

Aris Baras, MD

Senior Vice President and Head of Regeneron Genetics Center (RGC)

Regeneron

Jeff Boyd, PhD

Chief Scientific Officer, Dir. Center for Genomic Medicine

Northwell Health Cancer Institute

Brianna Cartwright, MS

Principal Research Analyst

Truveta

Ty Gluckman, MD

Medical Director

Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at Providence St. Joseph Health

Rod Hochman, MD

CEO Emeritus

Providence

Michael Jaff, DO, FACC

Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions

Boston Scientific

Scott Kelly

Global Epidemiology

Pfizer

Joseph Levy, PhD

Assistant Professor

Johns Hopkins Bloomberg School of Public Health

Jay Lusk, MD, MBA

Duke University Health System

Michael Mack, MD

Co-Chair, NeuroARC and Chair, Cardiovascular Governance Council, and Medical Director, Cardiovascular Surgery

Baylor Scott & White Health

Terry Myerson

CEO and co-founder

Truveta

Petros Okubagzi, MD

Director, Cardiovascular Research Programs

MedStar Health

Ishu V. Rao, MD

Senior Vice President of Medical Affairs

Impulse Dynamics

Tricia Rodriquez, PhD, MPH

Principal Applied Scientist

Truveta

Heather A. Rubino, PhD, MS

Head, Safety Surveillance Research

Pfizer

Michael Simonov, MD

VP of Product

Truveta

Nasa Sinnott-Armstrong, PhD

Assistant Professor, Herbold Computational Biology Program Public Health Sciences Division

Fred Hutch Cancer Center

Ken Stein

SVP and Global Chief Medical Officer

Boston Scientific

David Tingley, PhD

Co-founder and CEO

Olio Labs

Michelle Tressler, PhD

Vice President, Strategic Planning

Dexcom

Evelyn Vanvlasselaer

Global Head of Target Outputs

Boehringer-Ingelheim

“Trusted real-world data has the potential to advance care, address health inequities, and accelerate science. It is an honor to bring together innovative industry leaders and renowned researchers across health systems, public health, and life science at Truveta Symposium this week. The collaborations established here have the potential to rapidly accelerate our shared mission of Saving Lives with Data.”

Terry Myerson

Chief Executive Officer & co-founder, Truveta

“We have an opportunity to democratize care by connecting leaders across healthcare to learn, collaborate, and dream together. Truveta Symposium enables us to join forces and accelerate progress in critical areas like cardiovascular, oncology, and rare diseases to advance care for everyone.”

Rod Hochman, MD

President & CEO, Providence; Truveta board chair

“From my earliest discussions with Truveta, I saw the unique opportunity for leaders across healthcare to come together with a shared mission. Truveta Symposium creates this opportunity for us to come together, explore fascinating research, and discuss the opportunities and challenges facing us today with much hope for the future.”